Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Equity Ratio (2019 - 2025)

Biodesix (BDSX) has disclosed Equity Ratio for 7 consecutive years, with 0.03 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Equity Ratio fell 113.13% year-over-year to 0.03, compared with a TTM value of 0.03 through Dec 2025, down 113.13%, and an annual FY2025 reading of 0.03, down 113.13% over the prior year.
  • Equity Ratio was 0.03 for Q4 2025 at Biodesix, down from 0.02 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.32 in Q1 2021 and bottomed at 0.09 in Q2 2023.
  • Average Equity Ratio over 5 years is 0.11, with a median of 0.11 recorded in 2022.
  • Peak annual rise in Equity Ratio hit 1727.28% in 2024, while the deepest fall reached 212.04% in 2024.
  • Year by year, Equity Ratio stood at 0.26 in 2021, then dropped by 14.44% to 0.22 in 2022, then tumbled by 79.16% to 0.05 in 2023, then skyrocketed by 364.49% to 0.21 in 2024, then crashed by 113.13% to 0.03 in 2025.
  • Business Quant data shows Equity Ratio for BDSX at 0.03 in Q4 2025, 0.02 in Q3 2025, and 0.01 in Q2 2025.